Books by splitShops

Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk: How to Analyze, Summarize and Interpret to Determine Risk - Paperback

$181.71

Tax not included.
Shipping calculated at checkout.

In stock

Order Note:

Purchase Information

Shipping charges, applicable taxes, the final order total, and available payment methods are shown during checkout before payment. Delivery timing varies by item and fulfillment origin. Standard U.S. returns are by mail for eligible new, unopened items within 30 days of carrier delivery. Customers pay standard return shipping; there is no restocking fee. Approved refunds are issued within 5 business days after the return is received and inspected. Standard exchanges are not offered.

Cindi Book items have a flat $9.99 shipping charge. Shopify Collective items use shipping rates set by the supplier. Orders containing items from different fulfillment sources may include more than one shipping charge. Your full shipping total is shown at checkout before payment.

Return eligibility is subject to the full policy. Opened, read, or unsealed books with broken seals or visible wear are final sale. Digital downloads, gift cards, and personalized products are non-refundable. Original shipping charges are not refunded for standard returns. Contact us within 7 days of delivery about damaged, defective, or incorrect items.

by Michael J. Klepper (Author), Barton Cobert (Author)

Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk was selected for The First Clinical Research Bookshelf - Essential reading for clinical research professionals by the Journal of Clinical Research Best Practices. Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk provides drug safety/pharmacovogilance professionals, pharmaceutical and clinical research scientists, statisticians, programmers, medical writers, and technicians with an accessible, practical framework for the analysis, summary and interpretation of drug safety data. The only guide of its kind, Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk is an invaluable reference for pre- and post-marketing risk assessment. With decades of pharmaceutical research and drug safety expertise, authors Dr. Klepper and Dr. Cobert discuss how quality planning, safety training, and data standardization result in significant cost, time, and resource savings. Through illustrative, step-by-step instruction, Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk is the definitive guide to drug safety data analysis and reporting. Key features include: * Step-by-step instruction on how to analyze, summarize and interpret safety data for mandatory governmental safety reports * Pragmatic tips...and mistakes to avoid * Simple explanations of what safety data are collected, and what the data mean * Practical approaches to determining a drug effect and understanding its clinical significance * Guidance for determining risk throughout the lifecycle of a drug, biologic or nutraceutical * Examples of user-friendly data displays that enhance safety signal identification * Ways to improve data quality and reduce the time, resources and costs involved in mandatory safety reporting * Relevant material for the required training of drug safety/pharmacovigilance professionals * SPECIAL FEATURE: Actual examples of an Integrated Analysis of Safety (IAS) -used in the preparation of the Integrated Summary of Safety (ISS) and the Summary of Clinical Safety (SCS) reports -, and the Periodic Safety Update Report (PSUR)

Number of Pages: 316
Dimensions: 0.8 x 10.8 x 8.4 IN
Illustrated: Yes
Publication Date: September 29, 2010

Pay with

  • Amazon
  • Apple Pay
  • Diners Club
  • Discover
  • Google Pay
  • Mastercard
  • PayPal
  • Shop Pay
  • Visa

Available payment methods and your final total are shown at checkout before payment.

$181.71